Please assess the completion status of the following clinical trial:

Trial Title: Dexamethasone and Block Duration in Upper Extremity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* age 18-75, no contraindication to regional anesthesia,~Exclusion Criteria:~* opioid user, chronic pain conditions, peripheral neuropathy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Bupivacaine (Type: ACTIVE_COMPARATOR): Control
- Bupivacaine with Dexamethasone (Type: EXPERIMENTAL): Dexamethasone will be mixed with bupivacaine
- Intravenous Dexamethasone (Type: ACTIVE_COMPARATOR): Dexamethasone will be given intravenously

Based on this trial design, predict the completion outcome and termination type (if applicable).